Critical Roles of the Sphingolipid Metabolic Pathway in Liver Regeneration, Hepatocellular Carcinoma Progression and Therapy

Hiroyuki Nojima,Hiroaki Shimizu,Takashi Murakami,Kiyohiko Shuto,Keiji Koda

DOI: https://doi.org/10.3390/cancers16050850

2024-02-21

Cancers

Abstract:The sphingolipid metabolic pathway, an important signaling pathway, plays a crucial role in various physiological processes including cell proliferation, survival, apoptosis, and immune regulation. The liver has the unique ability to regenerate using bioactive lipid mediators involving multiple sphingolipids, including ceramide and sphingosine 1-phosphate (S1P). Dysregulation of the balance between sphingomyelin, ceramide, and S1P has been implicated in the regulation of liver regeneration and diseases, including liver fibrosis and hepatocellular carcinoma (HCC). Understanding and modulating this balance may have therapeutic implications for tumor proliferation, progression, and metastasis in HCC. For cancer therapy, several inhibitors and activators of sphingolipid signaling, including ABC294640, SKI-II, and FTY720, have been discussed. Here, we elucidate the critical roles of the sphingolipid pathway in the regulation of liver regeneration, fibrosis, and HCC. Regulation of sphingolipids and their corresponding enzymes may considerably influence new insights into therapies for various liver disorders and diseases.

oncology

What problem does this paper attempt to address?

The paper primarily explores the critical role of sphingolipid metabolic pathways in liver regeneration, liver fibrosis, and the progression of hepatocellular carcinoma (HCC). Specifically, it focuses on the mechanisms and potential therapeutic strategies involving sphingolipid metabolites such as ceramide, sphingosine-1-phosphate (S1P), and their receptors in these processes.

1. **Liver Regeneration**: The paper points out that the sphingolipid metabolic pathway plays an important role in liver regeneration, particularly in the balance regulation of ceramide and S1P. Studies have shown that after partial hepatectomy, the activity of acid sphingomyelinase increases, accompanied by a rise in ceramide levels and a decrease in S1P, which contributes to hepatocyte proliferation. Additionally, S1P promotes hepatocyte proliferation and anti-apoptotic effects by activating S1P receptors.

2. **Liver Fibrosis**: Elevated S1P levels are associated with the activation of hepatic stellate cells (HSCs), leading to the development of liver fibrosis. Research has found that the expression of S1P receptors S1PR1 and S1PR3 increases, participating in the regulation of angiogenesis and the migration and activation of HSCs during liver fibrosis. Inhibiting S1PR2 can alleviate liver inflammation and fibrosis.

3. **Hepatocellular Carcinoma (HCC)**: Dysregulation of the sphingolipid metabolic pathway may promote the occurrence and development of HCC. S1P promotes tumor vascular invasion and epithelial-mesenchymal transition (EMT) by activating S1PR1, thereby enhancing tumor metastasis. Patients with high S1PR1 expression have a poorer prognosis and are associated with vascular invasion and intrahepatic metastasis.

In summary, this paper aims to reveal the key mechanisms of the sphingolipid metabolic pathway in liver regeneration, liver fibrosis, and HCC progression, and to explore the therapeutic potential targeting this pathway.